Previous Page  10 / 20 Next Page
Information
Show Menu
Previous Page 10 / 20 Next Page
Page Background

Page 30

Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8

&

&

October 29-30, 2018 | San Francisco, USA

International Conference on

Gastrointestinal Cancer and Therapeutics

4

th

World Congress on

Digestive & Metabolic Diseases

26

th

Annual Congress on

Cancer Science and Targeted Therapies

Non-invasive, early diagnostic methods of various cancers and their metastases. Role of coexisting

contributing factors of Human papilloma virus-Type 16 and

Toxoplasma gondii

infection and strong,

electromagnetic field, etc. for rapid cancer development (some cancers may be infectious): Safe, effective

treatment of various cancers using non-invasive, safe, effective, simple, individualized treatment by

combined use of optimal dose of vitamin D3 and thymus gland stimulation

A

s non-invasive, early diagnostic methods of various cancers, we developed following 5 newmethods: 1) visible and invisible

changes appearing at different parts of the face including eyebrow, alars of the nose, upper and lower lips, and thymus gland

representation areas on the face & hands 2) One-Page Mouth, Hand, and Foot Writing Form, cancer can be detected without

knowing anything about the patient, 3) detection of cancer from rapidly changing QRS Complex of ECGs, 4) abnormal thymus

gland representation area, 5) bone marrow representation areas of each side of the face. Recently we found in the presence of

multiple cancer-contributing factors, cancer can develop in less than few months. The important common factors we found

is co-existence of Human Papilloma Virus-Type 16 (HPV-16) and single-cell

Toxoplasma gondii

as well as frequent strong

electromagnetic field (EMF) exposure from cellular phone & strong negative underwear, metal products on the body surface,

and toxic drinks & food. Therefore, some of rapidly developed cancer is infectious. Ideal treatment of cancer has to eliminate

their infection in addition to inhibition or killing or elimination of cancer cells. We succeeded in developing ideal cancer

treatment by combined use of 8 unique, beneficial effects of optimal dose of vitamin D3 and 50-time manual stimulation of

thymus gland representation area on the back of L-hand was found to be most safe, effective treatment. Among these 8 unique,

beneficial effects, most important ones are 1) very safe, strong anti-cancer effects including significant decrease in 8-OH-dG,

which is proportional to DNA mutation and is required for cancer growth, 2) its improved circulation, 3) it has significant

urinary excretion effects of Viruses, Bacteria, Fungi, single-cell parasites, and Toxic substances, including Asbestos & metals

such as Hg, Pb, & Al, 4) about 15-time increase of Thymosin α1 which is increased in all the thymus gland representation areas

on different parts of the body. As one of the most important & significant effects of 50-time manual stimulation of back of

L-hand which increases Thymosin α1, 15 times of normal amount which is usually about 20ng. Even without stimulating any

other thymus gland representation areas including main thymus gland at manubrium & rest of thymus gland representation

areas at rest of the body are all activated and produced same changes as stimulated side of L-hand. Thymosin α1 is one of main

hormones excreted from thymus gland and it is well-known that it has very significant anti-cancer effects. When we do this

combined stimulation, total amount of increase in Thymosin α1 becomes total of about 30 times of non-stimulated condition.

Since effect of optimal dose of vitamin D3 lasts about 6~8 hours, thymus gland stimulation effect also lasts close to similar time

duration. We have been using every 6~8 hours, depending on the patient. So far, anti-cancer effect was very significant. We

hope many advanced cancer patients can be saved by this method. So far, we are able to save number of terminal cancer patients

which could not improved by standard cancer hospital treatment.

Biography

Yoshiaki Omura received Oncological Residency training at Cancer Institute of Columbia University & Doctor of Science Degree through research on Pharmaco-

Electro-Physiology of Single Cardiac Cells

in-vivo

and

in-vitro

from Columbia University. He researched EMF Resonance phenomenon between 2 identical molecules

for non-invasive detection of molecules, at Graduate Experimental Physics Department, Columbia University, for which he received US patent.

icaet@yahoo.com

Yoshiaki Omura

New York Medical College, USA

Yoshiaki Omura, J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C8-084